지더블유바이텍 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 백옥생코리아, was filed 20 Dec 2024.
지더블유바이텍: what insiders have been doing
This page follows insider dealings at 지더블유바이텍 as filed with DART (FSS), a company from the Health Care sector. The past year has been quiet: not a single insider filing for 지더블유바이텍. The previous disclosure was published on 20 December 2024.
Elsewhere in the same sector, our signals recently picked up insider purchases at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleFinancial data
· cache
- 8,115,096 sharesKRXDART:20241220000683Canonical exit: 13 Mar 2025 (T+90)
- 21,122,578 sharesKRXDART:20241220000418Canonical exit: 30 May 2024 (T+90)
- ShareKRXDART:20241220000685Canonical exit: 23 Jun 2024 (T+90)
- ShareKRXDART:20241220000420Canonical exit: 30 May 2024 (T+90)
- ●Executives0DART
- 21,122,578 sharesKRXDART:20231127000378Canonical exit: 22 Feb 2024 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ShareKRXDART:20230920000359
- 21,122,578 sharesKRXDART:20230920000355Canonical exit: 19 Dec 2023 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 21,122,578 sharesKRXDART:20230908000176Canonical exit: 29 Nov 2023 (T+90)
- 21,122,578 sharesKRXDART:20230906000106Canonical exit: 29 Nov 2023 (T+90)
- ●Executives0DART
- 21,122,578 sharesKRXDART:20230823000012Canonical exit: 21 Nov 2023 (T+90)
- 21,122,578 sharesKRXDART:20230616000055Canonical exit: 12 Sept 2023 (T+90)
- 21,122,578 sharesKRXDART:20230331002959Canonical exit: 29 Jun 2023 (T+90)
- ShareKRXDART:20230329000006
- ●Executives0DART
- ShareKRXDART:20230307000041
25 of 62 declarations
About 지더블유바이텍
지더블유바이텍 is a company listed on the XKRX market, specializing in the health and pharmaceutical sector. It focuses on the development and commercialization of innovative pharmaceutical products.
